Bradykinin-induced plasma extravasation and mechanical hyperalgesia are sympathetic-dependent components of inflammation. Noxious stimulation has been found to inhibit bradykinin-induced plasma extravasation by activating the hypothalamo-pituitary-adrenal axis. The sensitivity of this nociceptive-neuroendocrine feedback control of inflammation is modulated by activity in subdiaphragmatic vagal afferents. In the present study, we tested the hypothesis that activity in the subdiaphragmatic vagus also modifies bradykinin-induced mechanical hyperalgesia in the rat, using the Randall-Selitto method.
Introduction
Bradykinin (BK) is a potent inflammatory mediator that produces hyperalgesia and plasma extravasation. Both effects are known to be mediated, at least in part, by an action of BK on the peripheral terminals of sympathetic postganglionic neurones (Levine et al., 1986; Miao et al., 1996b, c) .
In recent studies we found that BK-induced plasma extravasation of the rat knee joint synovium is inhibited during stimulation of nociceptive cutaneous and visceral afferents. This inhibition is exerted by activation of the hypothalamo-pituitary-adrenal (HPA) axis (Green et al., 1995; Miao et al., 1997a, b) . The final signal for this inhibition is a corticosteroid, released from the adrenal cortex (Green et al., 1997) . The sensitivity of this nociceptive-neuroendocrine negative feedback control is modulated by activity in abdominal vagal afferents. Specifically, the inhibition of BK-induced plasma extravasation gener-ated by this negative feedback loop is potentiated by about two orders of magnitude after cutting the subdiaphragmatic vagus nerve (Miao et al., 1997a, b) . The same potentiation occurs after selectively cutting the coeliac branches of the subdiaphragmatic vagus nerve but not after cutting the gastric or hepatic branches (Miao et al., 1997b) , demonstrating that afferents from the small intestine which project through the coeliac branches are probably involved in the vagal inhibition of the central nociceptive system which activates the HPA axis.
Gebhart, Randich and co-workers have shown that, in the rat, activity in vagal afferents from abdominal organs modulates transmission of nociceptive impulses in the spinal cord and probably elsewhere in the central nervous system as well as experimental pain behaviour. Both are enhanced during electrical stimulation of large-diameter and inhibited during electrical stimulation of small-diameter vagal afferents (for reviews, see . Vagal inhibition acts continuously on the central nociceptive pathway. Therefore, on the basis of our previous studies and those of Gebhart, Randich and co-workers, one would expect that subdiaphragmatic vagotomy might have two effects on mechanical nociceptive behaviour in the rat. Firstly, to enhance hyperalgesic behaviour irrespective of the way the nociceptive afferents are being sensitized (e.g. by BK or prostanoids) and, secondly, to lower baseline threshold to mechanical stimulation. Alternatively, there might be effects of abdominal vagal afferents on peripheral nociceptors via the sympatho-adrenal medullary system or the HPA axis.
In this study, we have examined the effect of subdiaphragmatic vagotomy on the baseline paw-withdrawal threshold elicited by mechanical stimulation of the dorsum of the rat hindpaw and on the decrease of mechanical paw-withdrawal threshold (behavioural mechanical hyperalgesia), induced by either BK or by the directacting hyperalgesic agent prostaglandin E 2 (PGE 2 ), injected intradermally into the dorsal surface of the hindpaw of the rat.
Materials and methods
The experiments were performed on 92 lightly restrained male Sprague-Dawley rats (250-350 g) purchased from Bantin and Kingman (Fremont, CA, USA) and housed in the animal care facility of the University of California, San Francisco under a 12-h light/ dark cycle. Animal care and use conformed to NIH guidelines for care and use of experimental rats. Experimental protocols were approved by the University of California, San Francisco Committee on Animal Research. The nociceptive flexion reflex was quantified by using a Basile Algesimeter (Stoelting, Chicago, IL, USA), which applies a linearly increasing mechanical force to the dorsum of the rat's hindpaw.
Before using the rats for experiments, they were trained in the paw-withdrawal reflex test at 5-min intervals for 1 h each day for a period of 1 week. This training procedure reduces variability and produces a stable baseline paw-withdrawal threshold [minimum force (g) at which the rat withdraws its paw] measurement, thereby enhancing the ability to detect the effect of agents which modulate nociception . On the day of the experiments, pawwithdrawal thresholds were measured (i.e. rats were again exposed to the test stimulus) at 5-min intervals for 1 h. The mean of the last six paw-withdrawal thresholds was determined. This mean is defined as the baseline paw-withdrawal threshold, before the injection of a test agent. Test agents [BK (0.1-1000 ng); PGE 2 (1-1000 ng); the B 1 receptor agonist des-Arg9-BK (1-1000 ng)] were injected intradermally, into the dorsum of both hindpaws, in volumes of 2.5 µL. Thresholds for paw-withdrawal were then re-determined at 10, 15 and 20 min after each injection. The mean of the pawwithdrawal thresholds obtained at these three time-points is the mechanical nociceptive threshold at the dose of the test agent used. Increasing doses of test agents, each an order of magnitude greater than the previous dose, were injected, cumulatively, at 25-min intervals. Because we have found that injection of small volumes of test agents locally in one paw does not affect the threshold of the contralateral paw (unpublished observation), each paw was treated as an independent measure. In animals treated with indomethacin, 4 mg/ kg indomethacin was injected i.p. 30 min prior to testing with BK; then indomethacin (1 µg) was coinjected with every other dose of BK intradermally.
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Surgical procedures
Surgery was performed on rats in groups of six at a time. Surgical procedures were performed on three rats while the other three were used for sham surgery, as controls.
Subdiaphragmatic vagotomy and selective cutting of branches of the subdiaphragmatic vagus nerve
After lateral incision of the abdominal wall in the left upper quadrant, the oesophagus was fully exposed at the subdiaphragmatic level (Prechtl & Powley, 1985; Prechtl & Powley, 1986; Miao et al., 1994 ). The vagus nerve was then dissected free from the oesophagus and cut, bilaterally. A 2.0-2.5-cm section of the subdiaphragmatic vagus nerve, together with its fine branches, were removed during the surgery. Sham surgery was performed in the same way without cutting the abdominal vagus nerve.
Three other groups of vagotomized rats were used. Animals of one group were treated with indomethacin on day 7 following vagotomy. The other two groups were used to test the effects of des-Arg9-BK and PGE 2 , each on day 7 following vagotomy.
For selective cutting, the branches of the subdiaphragmatic vagus nerve (hepatic, left and right gastric, and coeliac and accessory coeliac) were identified, as described previously (Prechtl & Powley, 1985 Miao et al., 1996a) , after exposure of the region of the gastro-oesophageal junction. The coeliac and accessory coeliac branches were then cut, leaving the other branches intact. Sham surgeries were performed in the same way except that no branch was cut. In another group of rats, the hepatic and both gastric branches were cut while the coeliac and accessory coeliac branches were left intact. Changes of paw-withdrawal thresholds to mechanical stimulation after intradermal BK-injections were determined in these rats 7 days after surgery.
Rats were between 250 and 270 g in weight at the time of subdiaphragmatic surgery. Most vagotomized rats did not display any overt changes in general behavioural pattern. After losing some weight in the first week following the surgery the rats recovered. If vagotomized rats did not begin to eat within 24 h after surgery, they were unlikely to fully recover; these rats were excluded from the experiments. Animals undergoing the other types of surgery (selective cutting of the coeliac branches of the abdominal vagus nerve; lumbar sympathectomy; decentralization of the lumbar sympathetic trunk) did not display any abnormality in their behaviour.
Sympathectomy
In order to test whether the effect of vagotomy on BK-induced hyperalgesia was dependent on the presence of intact sympathetic postganglionic neurones, rats were surgically sympathectomized or surgically sympathectomized and subdiaphragmatically vagotomized. Sympathectomy was carried out as previously described by Baron et al. (1988) . Briefly, the sympathetic chains, from L 1 -L 4 ganglia, were surgically removed, bilaterally, via a lateral, extraperitoneal approach. This procedure accomplishes virtually complete sympathetic denervation of the hind limbs (Baron et al., 1988) . Mechanical nociceptive testing with BK in sympathectomized or sympathectomized plus vagotomized rats was determined 7 days after surgery.
Decentralization of the lumbar sympathetic trunk
In order to determine the contribution of activity in preganglionic sympathetic neurones to enhancement of BK-induced hyperalgesia both lumbar sympathetic trunks were decentralized (cutting of the preganglionic axons). Both lumbar sympathetic chains, from paraver-tebral ganglia L 2 to L 4 , were exposed surgically, via a lateral, extraperitoneal approach, from the left side. The white rami to the left and right ganglia L 2 and to the left and right ganglion L 3 in rats where it existed (Baron et al., 1988; , were cut. In addition, the left lumbar sympathetic chain was transected rostral to the ganglion L 2 and the contralateral chain was cut between the paravertebral ganglia L 2 and L 3 . Mechanical nociceptive testing with BK in vagotomized and sympathetically decentralized rats was carried out either 3 days after sympathetic decentralization or 7 days after vagotomy and 3 days after sympathetic decentralization.
Drugs used
Agents used in this study were: bradykinin (BK; a preferential B 2 agonist) and prostaglandin E 2 (PGE 2 ) (Sigma, St Louis, MO, USA); des-Arg9-bradykinin (a selective B 1 -type BK agonist; a gift from Scios Nova Inc., Baltimore, MD, USA) and, sodium indomethacin trihydrate (a cyclo-oxygenase inhibitor, a gift from Merck, Rahway, NJ, USA). PGE 2 (4 mg/mL) was dissolved in 10% ethanol in saline. Further dilutions of PGE 2 were done in saline. The highest concentration of ethanol injected into the paw did not exceed 1%. All other drugs were dissolved in saline vehicle.
Groups of rats tested
The groups of rats tested for the different experimental interventions were independent. For each group of rats undergoing surgery, a sham control group was also studied. Experiments in which the time course of decrease in paw-withdrawal threshold and of enhanced BKinduced mechanical hyperalgesia following vagotomy were evaluated, independent subgroups were tested on: only 1 day (day 7 or 14), 2 days (days 1 and 7, days 3 and 7, days 7 and 14), 3 days (days 1, 3 and 7) or all days following vagotomy. Experimental control groups of animals which underwent sham-vagotomy were tested repeatedly up to day 14 after surgery in order to show that baseline paw withdrawal threshold and BK-induced mechanical hyperalgesia did not change significantly during repeated testing (see Fig. 5 ). Because the effects of vagotomy on paw-withdrawal threshold and BK-induced hyperalgesia at corresponding time-points were not significantly different, whether tested only once or repeatedly, the results of corresponding time-points were pooled.
Statistical analysis
Data are presented as mean Ϯ standard error of the mean (SEM) and analysed statistically using one factor or repeated measures analysis of variance (ANOVA). The one-factor ANOVA was used to analyse baseline paw-withdrawal threshold in the different groups of rats. Because data for the vagotomy and sham vagotomy groups at day 7 were the common reference for the different experimental groups, irrespective of the surgical manipulation, all the data for baseline paw-withdrawal were analysed together at the same time. Fisher's Protected Least Significant Difference (PLSD) post hoc test was used to determine pairs of groups where differences occurred. The repeated measures ANOVA was used to analyse dose-response relationships. All groups that had received BK, as test agent, were analysed at the same time, irrespective of the surgical procedure they had undergone. The groups treated with PGE 2 and des-Arg9-BK were analysed separately. Again, Fisher's PLSD post hoc test was used to determine the specific pairs of groups between which differences occurred. In all cases, P Ͻ 0.05 was the accepted level for statistical significance. Table 1 was analysed using one factor ANOVA. There were significant differences between the groups F ϭ 24.29; P Ͻ 0.01. *Significantly different from normal or sham vagotomy groups (P Ͻ 0.01, Fisher's PLSD). Also, baseline thresholds of Symp. decentralization ϩ vagotomy were significantly different from Symp. decentralization alone (P Ͻ 0.01) and sympathectomy ϩ vagotomy significantly different from sympathectomy alone (P Ͻ 0.01). Symp. ϭ sympathetic.
Results

Effect of vagotomy on baseline paw-withdrawal threshold and BK-induced hyperalgesia
Baseline paw-withdrawal threshold in normal and sham-vagotomized rats were 109 and 107 g, respectively. This mechanical baseline threshold significantly decreased to 89 g, 7 days after subdiaphragmatic vagotomy (P Ͻ 0.001; see Table 1 ). Intradermal injection of BK (0.1-1000 ng) induced a dose-dependent decrease in mechanical nociceptive threshold (i.e. mechanical hyperalgesia) in normal rats and in rats 7 days after subdiaphragmatic sham-vagotomy. The two curves were not significantly different from each other (P Ͼ 0.05). BK-induced hyperalgesia was significantly enhanced 7 days after subdiaphragmatic vagotomy. The dose-response curve was significantly shifted to the left compared with the sham vagotomized rats ( Fig. 1 ; P Ͻ 0.001).
Intradermal injection of the selective B 1 -receptor agonist des-Arg9-BK (1-1000 ng) into the dorsum of the paw did not produce hyperalgesia, either in vagotomized or in sham-vagotomized rats ( Fig. 2A ; F ϭ 0.01; P Ͼ 0.05). Thus, BK probably interacts with the B 2 -receptor to produce hyperalgesia in these animals.
Effect of indomethacin on baseline paw-withdrawal threshold and BK-induced hyperalgesia in vagotomized and sham vagotomized rats BK-induced hyperalgesia was significantly attenuated by indomethacin after sham vagotomy, as previously reported for normal rats see (Levine et al., 1986) . Indomethacin, however, had no significant effect on BK-induced hyperalgesia in vagotomized rats (Fig. 2B ). Indomethacin also, partially but significantly reversed vagotomyinduced decrease in baseline paw-withdrawal threshold but had no effect on baseline paw-withdrawal in sham vagotomized rats (see baseline in Fig. 2 ; P Ͻ 0.05, Fisher's PLSD post hoc test).
Effect of vagotomy on hyperalgesia induced by PGE 2 PGE 2 (1-1000 ng), a hyperalgesic agent acting directly on terminals of nociceptive afferents , induced a dosedependent hyperalgesia in both vagotomized and sham-vagotomized rats. The dose-response relationships of the hyperalgesia induced by FIG. 1. Decrease of paw-withdrawal threshold to mechanical stimulation of the dorsum of the rat hindpaw induced by bradykinin (BK-induced behavioural mechanical hyperalgesia) in normal control (squares, n ϭ 26), vagotomized (triangles, n ϭ 16) and sham vagotomized (circles, n ϭ 18) paws. Experiments conducted 7 days after vagotomy. Post hoc test showed significant differences between vagotomized and normal (P Ͻ 0.05) as well as between vagotomized and sham vagotomized (P Ͻ 0.05) rats, in response to BK. Cutaneous mechanoreceptors in the hairy skin were stimulated by a linearly increasing mechanical force using an algesimeter. Threshold is defined as the minimum force (g) at which the paw is withdrawn by a rat. Ordinate scale expresses paw-withdrawal threshold in grams. The abscissa scale is the log dose of BK (in ng) injected in 2.5 µg saline into the dermis of the skin of the dorsal aspect of the hindpaw. In this and subsequent figures, Vagx ϭ vagotomized. PGE 2 in these two groups were not significantly different when compared with each other and not different from PGE 2 -induced hyperalgesia in normal rats ( Fig. 3 ; F ϭ 0.53, P Ͼ 0.05).
Time course of development of decrease of mechanical baseline paw-withdrawal threshold and of enhancement of BK-induced hyperalgesia following vagotomy
The decrease in baseline paw-withdrawal threshold was observed as early as 24 h after vagotomy and reached 20-30 g below the prevagotomy baseline, after about 2 weeks [ Table 1 ; Figs 4A, 5 (day 1 data not shown)]. The decrease was already statistically significant on day 3 after vagotomy when compared with the baseline paw-withdrawal threshold in sham-vagotomized rats (P Ͻ 0.01). Repeated testing of sham-vagotomized rats did not lead to a decrease in baseline pawwithdrawal threshold over 14 days (closed circles in Fig. 4A) .
Enhancement of BK-induced hyperalgesia following subdiaphragmatic vagotomy also could be detected as early as 24 h and reached a maximum 14 days after vagotomy (data beyond day 14 not shown). This enhancement was significantly different from sham-vagotomized rats on all days following vagotomy ( Fig. 5 ; P Ͻ 0.001). The change in paw-withdrawal threshold (i.e. the difference between paw-withdrawal threshold elicited by BK and baseline paw-withdrawal threshold), in response to 1 ng BK, had a time-course following vagotomy which was similar to the decrease in baseline paw-withdrawal threshold (Fig. 4B) . Repeated testing of sham-vagotomized control rats over 14 days did not reveal a change in baseline paw-withdrawal threshold or a decrease in paw-withdrawal threshold produced by 1 ng BK (closed circles in Fig. 4B ). The decrease was statistically significant ജ 3 days after vagotomy when compared with these controls (P Ͻ 0.05).
Two aspects of these results should be emphasized: firstly, the changes in baseline paw-withdrawal threshold as well as in BKinduced hyperalgesia following subdiaphragmatic vagotomy take ജ 2 weeks to reach their maximum (data beyond 2 weeks not shown). Secondly, the paw-withdrawal threshold produced by 1 ng BK is 50-60 g lower, 2 weeks after vagotomy than in sham-vagotomized rats.
Baseline mechanical threshold and BK-induced mechanical hyperalgesia after selective cutting of branches of the subdiaphragmatic vagus nerve
The question arises as to whether all subdiaphragmatic vagal afferents are involved in the inhibitory control of baseline paw-withdrawal threshold to cutaneous stimulation and of BK-induced mechanical hyperalgesia or only a subset of them. A preliminary answer to this question is given by experiments in which the different major branches of the abdominal vagus nerve are cut selectively. No significant change of either parameter occurred after cutting the hepatic and gastric branches of the vagus nerve (Fig. 6 , Table 1 ; P Ͼ 0.05). However, after cutting the coeliac and accessory coeliac branches of the vagus nerve, BK-induced hyperalgesia was enhanced compared to sham-operated controls ( Fig. 6 ; P Ͻ 0.001). However, baseline paw-withdrawal threshold did not change (Table 1 , P Ͼ 0.05).
Baseline mechanical threshold and BK-induced mechanical hyperalgesia after decentralization of the sympathetic chain or surgical sympathectomy
Decentralization of the lumbar sympathetic chain (cutting the preganglionic axons) did not significantly change the baseline paw-withdrawal threshold to mechanical stimulation of the dorsum of the paw when compared with normal rats (Table 1 , P Ͼ 0.05). Surgical sympathectomy led to a small but significant decrease in baseline paw-withdrawal threshold compared to sham-operated or normal rats (Table 1 , P Ͻ 0.05). This decrease may be due to changes of blood flow through skin and deep tissues following sympathectomy.
BK-induced hyperalgesia was almost absent after surgical sympathectomy (P Ͻ 0.001) but did not change after decentralization of the sympathetic chain when compared with a group of shamsympathectomized rats ( Fig. 7A ; P Ͼ 0.05). The difference between sympathectomized and control rats was particularly marked at 100 and 1000 ng BK (Fig. 7A) .
Effect of vagotomy on mechanical baseline threshold and BKinduced mechanical hyperalgesia after surgical sympathectomy and decentralization of the sympathetic chain
Baseline mechanical threshold decreased significantly in both groups of rats (i.e. sympathectomized and decentralized) 7 days after vagotomy when compared with rats which were both sham-sympathectomized and sham-vagotomized (sham data not shown) (Table 1 ; P Ͻ 0.001). This decrease in baseline threshold was not significantly different from that observed in rats which were only vagotomized (Table 1 ; P Ͼ 0.05).
In sympathectomized and vagotomized rats, there was almost a parallel shift of paw-withdrawal thresholds for BK doses of 0.1-10 ng, compared with rats which were only sympathectomized; this difference between both groups of rats became larger for BK doses of 100 and 1000 ng (compare open circles in Fig. 7B with open squares in Fig. 7A ). The decrease in BK-induced paw-withdrawal threshold was significantly smaller in sympathectomized plus vagoto-
FIG. 2. (A)
Effect of des-Arg9-BK (a selective B 1 -receptor agonist) in sham-vagotomized and vagotomized rats. des-Arg9-BK had no effect paw-withdrawal threshold in both groups of rats (F ϭ 0.01, P Ͼ 0.05; n ϭ 6 paws in each group, repeated measures ANOVA). (B) Bradykinin (BK)-induced mechanical hyperalgesia in sham-vagotomized and vagotomized rats before and after systemic pretreatment with indomethacin plus local intradermal injection of indomethacin. 4 mg/kg indomethacin was injected intraperitoneally 30 min before paw-withdrawal measurements. Also, indomethacin (1 µg) was coinjected with BK intradermally in the course of the experiment. Vagotomy (triangles) and sham-vagotomy (circles) data from Figure 1(A) , are shown for the purpose of comparison. BK-induced hyperalgesia was almost completely abolished by indomethacin in sham vagotomized rats (P Ͻ 0.01; n ϭ 6 paws) but it persisted in vagotomized rats. Compared to untreated vagotomized rats, there was no significant difference (P Ͼ 0.05, n ϭ 6 paws).
FIG. 3.
Mechanical hyperalgesia induced by intradermal injection of prostaglandin E 2 (PGE 2 ) in: normal (squares), vagotomized (triangles), and sham vagotomized (circles) rats. Experiments conducted 7 days after vagotomy. There were no significant differences between the groups of rats (F ϭ 0.53; P Ͼ 0.05; repeated measures ANOVA). n ϭ 6 paws in each group. mized rats than in rats which were only vagotomized (P Ͻ 0.01). This difference was particularly obvious at BK doses of 0.1-10 ng (compare open triangles with open circles in Fig. 7B ).
BK-induced hyperalgesia was not different between rats in which the sympathetic chain was decentralized and which were vagotomized compared with rats which were only vagotomized (compare closed squares with open triangles in Fig. 7B ; P Ͼ 0.05).
In summary, mechanical paw-withdrawal thresholds to 1 ng BK: (i) are not significantly different between normal and sympathectomized rats; (ii) are significantly lower in vagotomized rats than in vagotomized plus sympathectomized rats and (iii) do not change after decentralization of the lumbar sympathetic chain, either in normal or in vagotomized rats.
Conclusion and hypothesis
Figure 8 schematically summarizes the afferent, central and efferent pathways which may mediate the effects of subdiaphragmatic vagotomy on BK-induced mechanical hyperalgesia and on mechanical baseline paw-withdrawal threshold. Intradermal injection of BK in hairy skin reduces paw-withdrawal threshold to mechanical stimulation, i.e. generates mechanical hyperalgesia. This type of mechanical hyperalgesia is alleviated by sympathectomy (S 2 ) but not by decentralization of the sympathetic chain (S 1 ); thus it is dependent on the presence of the sympathetic terminals in skin but not on the activity in the sympathetic neurones. Subdiaphragmatic vagotomy (V 1 ) reduces baseline paw-withdrawal threshold to mechanical stimulation and enhances the BK-induced mechanical hyperalgesia. These changes do not occur when the gastric and/or hepatic branches of the abdominal FIG. 4. (A) . Baseline paw-withdrawal threshold and (B) change in paw-withdrawal threshold in response to 1 ng bradykinin (BK) injected intradermally in vagotomized and sham vagotomized rats 1-14 days after surgery. Ordinate scale in (A) is absolute threshold (in grams) and in (B) difference between response to intradermal injection of 1 ng BK and baseline paw-withdrawal threshold in grams. There were significant differences between sham vagotomy and the vagotomy groups over the 14-day period in both (A) (F ϭ 46.72; P Ͻ 0.01) and (B) (F ϭ 49.91; P Ͻ 0.01, repeated measures ANOVA). n ϭ 6-32 paws per group, for vagotomized rats (see Table 1 ) and n ϭ 6 paws for sham vagotomized rats.
FIG. 5. Bradykinin (BK)-induced mechanical hyperalgesia 3-14 days after vagotomy. Maximum enhancement was present 14 days after vagotomy (squares). Fisher's PLSD post hoc test showed significant differences between all the vagotomized groups and the sham vagotomized group (P Ͻ 0.01). n ϭ 6-18 paws.
vagus nerves are interrupted (V 2 ). The enhancement of BK-induced hyperalgesia (but not the decrease of baseline paw-withdrawal threshold) occurs when the coeliac vagal branches are interrupted (V 3 ). It is hypothesized that activity in vagal afferents from the small and large intestines are responsible for the changes observed. Mechanical hyperalgesia generated by intradermal injection of the agent PGE 2 which acts directly on the afferent terminals is not enhanced after vagotomy. Therefore it is furthermore hypothesized that the effect of © 1998 European Neuroscience Association, European Journal of Neuroscience, 10, 435-444 FIG. 6. Bradykinin (BK)-induced mechanical hyperalgesia in shamvagotomized rats (circles), in vagotomized rats (triangles), in rats with cut coeliac plus accessory coeliac vagal branches (diamonds) and in rats with cut hepatic plus gastric vagal branches (inverted triangles). Data for vagotomized and sham vagotomized rats are the same as in Fig. 1 . Fisher's PLSD post hoc test showed significant differences between coeliac plus accessory coeliac vagotomized and hepatic plus gastric vagotomized rats (P Ͻ 0.05) as well as between subdiaphragmatically vagotomized and hepatic plus gastric vagotomized (P Ͻ 0.05) rats. n ϭ 8 paws in each group.
vagotomy is mediated by either of two neuroendocrine pathways: the hypothalamo-pituitary-adrenal (HPA) axis (pathway A) or the sympatho-adrenomedullary pathway (pathway B). These hypotheses are at present being tested in our laboratory. 
Discussion
In this study, we have found that subdiaphragmatic vagotomy decreased baseline mechanical paw-withdrawal threshold and enhanced BK-induced hyperalgesia. These effects reached their maximum in 2 weeks. Mechanical hyperalgesia generated by intradermal injection of PGE 2 is not enhanced after vagotomy. Dependence of BKinduced hyperalgesia on the presence of the sympathetic innervation in skin is partially lost after vagotomy, i.e. non-sympathetically dependent hyperalgesia is preferentially enhanced. Impulse activity in sympathetic neurones was found not to be necessary for the development of BK-induced hyperalgesia in normal or in vagotomized rats. Indomethacin blocked BK-induced hyperalgesia in normal rats but not in vagotomized rats, indicating a non-prostanoid dependent basis for BK hyperalgesia in vagotomized rats.
Although vagotomized rats lose some weight, they remain fairly healthy with no overt change in their behaviour. It is therefore unlikely that decrease in baseline paw-withdrawal threshold and enhanced BK-induced hyperalgesia can be attributed to a change in the general health status of the rats. This is supported by our finding that enhancement of BK-induced hyperalgesia can be mimicked by cutting the coeliac branches of the vagus nerve (see Fig. 6 ). Rats with this much smaller intervention at the vagus nerve do not lose weight and their paw-withdrawal threshold is not changed. In addition, adrenal medullectomy or denervation of the adrenal medulla by suprarenal ganglionectomy prevents the decrease in baseline pawwithdrawal threshold and the enhancement of BK-induced hyperalgesia occurring after vagotomy (S. G. Khasar, F. J.-P. Miao, W. Jänig and J. D. Levine, unpublished observation).
The effect of vagotomy
The enhancement of BK-induced hyperalgesia by vagotomy seems to depend on neurones projecting in the coeliac and accessory coeliac branches of the subdiaphragmatic vagus nerve, because section of these branches mimicked the effect of total subdiaphragmatic vagotomy, but not section of the hepatic and gastric branches (Fig. 6, 8) . However, unlike total vagotomy, cutting either the coeliac or hepatic and gastric branches of the subdiaphragmatic vagus nerve did not decrease the baseline paw-withdrawal threshold. These results suggest that, the decrease in baseline paw-withdrawal threshold, the enhancement of BK-induced hyperalgesia and the loss of sympathetic dependence, appear to be generated by different mechanisms. The fact that indomethacin pretreatment partially reversed the low baseline pawwithdrawal threshold suggests that endogenous prostaglandins contribute to this phenomenon.
What is the mechanism leading to enhancement of BK-induced hyperalgesia following vagotomy? Is the interruption of vagal afferent or vagal efferent (preganglionic) axons important? Previous experiments in our laboratories on rat knee joint synovial plasma extravasation showed that application of kainic acid to the nodose ganglia, which destroys vagal afferents, resulted in enhanced suppression of BK plasma extravasation by intrathecal nicotine, similar to that produced by subdiaphragmatic vagotomy. Also, electrical stimulation of the central stump of the subdiaphragmatic vagus reversed the enhancing effect of cutting this nerve on BK plasma extravasation. These results were interpreted to implicate vagal afferents rather than efferents in the enhanced suppression of BK plasma extravasation by intrathecal nicotine (Miao et al., 1994) . Our current results have similarities with the plasma extravasation results. Therefore, we FIG. 8 . A schematic diagram summarizing the afferent, central and efferent pathways which may mediate the effects of subdiaphragmatic vagotomy on bradykinin (BK)-induced mechanical hyperalgesia and on baseline mechanical paw-withdrawal threshold. Intradermal injection of BK in the hairy skin of the rat hindpaw, reduces paw-withdrawal threshold to mechanical stimulation, i.e. generates mechanical hyperalgesia. This type of mechanical hyperalgesia is alleviated by sympathectomy (S 2 ) but not by decentralization of the sympathetic chain (S 1 ). Thus, it is dependent on the presence of the sympathetic terminals in skin but not on the activity in the sympathetic neurones. Subdiaphragmatic vagotomy (V 1 ) reduces baseline paw-withdrawal threshold to mechanical stimulation and enhances the BK-induced mechanical hyperalgesia. These changes do not occur when the hepatic (1) and/or gastric (2) branches of the subdiaphragmatic vagus nerves are interrupted (V 2 ). The enhancement of BK-induced hyperalgesia (but not the decrease of baseline paw-withdrawal threshold) occurs when the coeliac vagal branches (3) are interrupted (V 3 ). Effects of lesions of the neuroendocrine pathways: hypothalamo-pituitary-adrenal (HPA) axis (pathway A) or the sympatho-adrenomedullary pathway (pathway B) are currently being studied. NTS ϭ nucleus of the solitary tract.
hypothesize that vagal afferents may be involved in the enhancement of BK-induced mechanical hyperalgesia. The failure of intradermal injection of PGE 2 to produce enhanced hyperalgesia after vagotomy suggests that enhancement of BK-induced hyperalgesia generated by vagotomy is not produced by removal of inhibition acting at the central nociceptive system. Section of the coeliac vagal branches, but not of the gastric and hepatic vagal branches, mimicked the effect of total subdiaphragmatic vagotomy to enhance BK-induced hyperalgesia. This is consistent with results showing that these branches mimic the effect of total vagotomy in enhancing the suppression of BK-induced plasma extravasation generated by noxious stimulation (Miao et al., 1994) or by intrathecal nicotine (Miao et al., 1997b) . The implication is that both vagotomy-induced phenomena share a common vagal afferent pathway.
Most afferents in the coeliac branch innervate the small intestine (duodenum, jejunum and ileum) and large intestine (Berthoud et al., 1991; Berthoud & Neuhuber, 1994) . They are tonically active because interruption of the coeliac branches enhances BK-induced hyperalgesia. The functional types of afferents involved are unknown. However, they monitor chemical and mechanical events that are related to meals: ingestion of poisonous substances, inflammation, obstruction, etc. (for review see Grundy, 1988) . Thus, these coeliac afferents may respond to distension or contraction of the organ and to intraluminal chemical stimulation (Schwartz & Moran, 1994 , 1996 Berthoud et al., 1995) . They seem to be important for regulation of meal size (Walls et al., 1995a, b) and for preabsorptive detection of energyyielding molecules and probably of other properties of nutrient solutions which may be deleterious to the gastrointestinal tract and potentially deleterious to the organism.
Dependence of BK-induced hyperalgesia on the sympathetic innervation
BK-induced mechanical hyperalgesia is dependent on the sympathetic innervation of the skin in normal rats (Levine et al., 1986) , as is also seen in this study. However, it is not dependent on impulse activity in the sympathetic postganglionic neurones, as shown here on rats with decentralized lumbar sympathetic trunks. Thus, BK-induced sensitization of cutaneous nociceptors is, at least in part, dependent on the presence of the sympathetic terminals and most likely independent of vesicular release of transmitter(s) from these terminals (Fig. 8) . These results are similar to those obtained on BK-induced plasma extravasation in the rat knee joint, where the neurogenic inflammatory process is largely dependent on the sympathetic terminals in the knee joint synovia, but not on activity in the sympathetic neurones and not on vesicular release of noradrenaline (Miao et al., 1996b, c; Green et al., 1997) . The mechanism underlying the dependence of BKinduced sensitization of cutaneous nociceptors to mechanical stimulation on the presence of sympathetic terminals in the skin is unknown and is currently being studied in our laboratory.
In animals which were vagotomized as well as sympathectomized BK-induced hyperalgesia was significantly attenuated but not abolished. This suggests that the enhancement of BK-induced hyperalgesia following vagotomy has two components: a component which is dependent on and a component which is independent of the sympathetic terminals. Interestingly, the component of BK-induced hyperalgesia which is dependent on the sympathetic terminals in vagotomized animals is seen at doses of BK (0.1-10 ng) which can occur in inflamed tissues Swift et al., 1993) . This dose-dependence is similar to that in BK-induced synovial plasma extravasation in the rat knee joint in that the sympathetic independent component is only seen at high doses of BK (Miao et al., 1996b) .
Effect of indomethacin on BK-induced hyperalgesia
A surprising result of this study is that indomethacin which blocks BK-induced hyperalgesia in normal animals had almost no effect on BK-induced hyperalgesia in vagotomized rats. This failure is not related to a switch from the B 2 -to the B 1 -receptor subtype as is the case in the setting of inflammatory hyperalgesia (Regoli et al., 1981; Perkins & Kelly, 1993; Davis & Perkins, 1994; Khasar et al., 1995) , because the selective B 1 agonist, des-Arg9-BK, failed to produce hyperalgesia in vagotomized rats (see Fig. 2 ). It shows that BK-induced hyperalgesia in vagotomized rats is not mediated by prostanoids.
Conclusion
We have shown that activity in subdiaphragmatic vagal afferents modulates BK-induced mechanical hyperalgesia and baseline mechanical paw-withdrawal threshold in the rat. Subdiaphragmatic vagotomy leads to selective enhancement of BK-induced hyperalgesia, which has two components; one is dependent and the other independent of the sympathetic postganglionic terminals in the skin. Furthermore, BK-induced hyperalgesia in vagotomized rats cannot be prevented by blocking prostanoid production with indomethacin. Experiments are under way to determine the mechanisms involved in the modulation of BK-induced hyperalgesia by activity in vagal afferents.
